TickerFacts.

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — Shareholders' Equity

Annual figures by period end, from SEC filings.

2007-12-31: $13.86B2008-12-31: $16.44B2009-12-31: $19.26B2010-12-31: $22.00B2011-12-31: $22.34B2012-12-31: $22.87B2013-12-31: $22.64B2016-01-06: $29.93B2016-12-31: $34.99B2017-12-31: $18.75B2018-12-31: $15.79B2019-12-31: $15.06B2020-12-31: $11.06B2021-12-31: $11.24B2022-06-30: $9.81B2022-09-30: $9.51B2022-12-31: $8.60B2023-03-31: $8.50B2023-06-30: $7.59B2023-09-30: $7.39B2023-12-31: $8.13B2024-12-31: $5.38B2025-12-31: $7.91B$7.91B
2007-12-31Shareholders' Equity (USD)2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$7.91B+47.1%2026-02-03Balance as of period end
2024-12-31$5.38B-33.8%2026-02-03Balance as of period end
2023-12-31$8.13B—2026-02-03Balance as of period end
2023-09-30$7.39B—2024-02-12Balance as of period end
2023-06-30$7.59B—2024-02-12Balance as of period end
2023-03-31$8.50B—2024-02-12Balance as of period end
2022-12-31$8.60B—2026-02-03Balance as of period end
2022-09-30$9.51B—2024-02-12Balance as of period end
2022-06-30$9.81B—2024-02-12Balance as of period end
2021-12-31$11.24B+1.7%2025-02-05Balance as of period end
2020-12-31$11.06B-26.6%2024-02-12Balance as of period end
2019-12-31$15.06B-4.6%2023-02-10Balance as of period end
2018-12-31$15.79B-15.7%2022-02-09Balance as of period end
2017-12-31$18.75B-46.4%2021-02-10Balance as of period end
2016-12-31$34.99B+16.9%2020-02-21Balance as of period end
2016-01-06$29.93B—2019-02-19Balance as of period end
2013-12-31$22.64B-1.0%2014-02-10Balance as of period end
2012-12-31$22.87B+2.3%2014-02-10Balance as of period end
2011-12-31$22.34B+1.5%2014-02-10Balance as of period end
2010-12-31$22.00B+14.2%2014-02-10Balance as of period end
2009-12-31$19.26B+17.2%2013-02-12Balance as of period end
2008-12-31$16.44B+18.6%2012-02-17Balance as of period end
2007-12-31$13.86B—2011-02-15Balance as of period end